Form 8-K - Current report:
SEC Accession No. 0001079973-13-000358
Filing Date
2013-05-17
Accepted
2013-05-17 09:00:26
Documents
4
Period of Report
2013-05-13
Items
Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K pure_8k.htm 8-K 30072
2 EXHIBIT 99.1 ex99x1.htm EX-99.1 8035
3 EXHIBIT 99.2 ex99x2.htm EX-99.2 10291
4 logo1.jpg GRAPHIC 4732
  Complete submission text file 0001079973-13-000358.txt   56672
Mailing Address 1725 GILLESPIE WAY EL CAJON CA 92020
Business Address 1725 GILLESPIE WAY EL CAJON CA 92020 619-596-8600
PURE BIOSCIENCE, INC. (Filer) CIK: 0001006028 (see all company filings)

EIN.: 330530289 | State of Incorp.: DE | Fiscal Year End: 0731
Type: 8-K | Act: 34 | File No.: 001-14468 | Film No.: 13853290
SIC: 2890 Miscellaneous Chemical Products